Research
Independent analysis of SEC filings, private funds, RIAs, websites and regulatory records.
Throne Labs SEC Form D Review 2026: $14.13M Sold as Smart Public Toilets Move From City Pilots to Infrastructure Contracts
Throne Labs, Inc. is a verifiable Delaware operating company whose September 2026 Form D reports a fixed $15 million Equity offering under Rule 506(b), with $14,132,384 sold to 36 investors and only $867,616 remaining. Fletcher Wilson is listed as executive officer and director, with Jessica Heinzelman, Benjamin Clark,
Throne Labs, Inc. · CIK 0001897136Read article →Is Mare Liberum Critical Technologies Fund I Legit? SEC Form D Review 2026: $25.8M Sold, 17 Investors and the $150M SBICCT Maritime-Tech Leverage Path
Mare Liberum Critical Technologies Fund I, LP is a verifiable 2025 Delaware pooled investment fund whose new September 15, 2026 SEC Form D reports $25,805,500 sold to 17 investors following a first sale on August 31, 2026. The fund uses Rule 506(c), relies on Section 3(c)(1), offers pooled investment fund interests, has an indefinite offering amount, reports a technical $0 minimum investment and shows $0 estimated sales commissions and finder's fees in Item 15. Mare Liberum Critical Technologies Fund I GP, LLC is the General Partner, Mare Liberum Capital Partners, LLC is the management company, and Erik Bethel, Marc Baliotti, Vrushank Vora and retired Rear Admiral Lorin Selby appear in the related-person chain. The filing also states that the management company will receive management fees based on the amount of securities sold. The distinctive story is much larger than the $25.8 million SEC number: Mare Liberum announced earlier in 2026 that a critical-technologies fund had received a green-light letter from the U.S. Small Business Administration and the Pentagon's Office of Strategic Capital under the SBIC Critical Technologies program, creating a path to as much as $150 million of low-cost government-guaranteed leverage if the fund completes the required licensing and program steps. :contentReference[oaicite:0]{index=0}
Mare Liberum Critical Technologies Fund I, LP · CIK 0002151169Read article →Is Mare Liberum Critical Technologies Fund I, LP Legit? SEC Form D Review 2026: $25.81M Sold, 17 Investors and a Maritime-Tech Platform Selected for DoD Strategic Capital
Mare Liberum Critical Technologies Fund I, LP is a verifiable 2025 Delaware pooled investment fund whose September 15, 2026 SEC Form D reports an indefinite offering with $25,805,500 sold to 17 investors after a first sale on August 31, 2026. The issuer relies on Rule 506(c) and Section 3(c)(1), offers pooled investment fund interests, intends the offering to last more than one year, shows a technical $0 minimum investment and reports $0 estimated sales commissions and finder's fees. Mare Liberum Critical Technologies Fund I GP, LLC is the General Partner, Mare Liberum Capital Partners, LLC is the management company, and Erik Bethel signed as Manager of the General Partner. BHA Select Network, LLC, CRD 168883, appears in the sales-compensation section for solicitation in Florida, Massachusetts and New York even though the filing estimates commissions at $0. The most important research point is that this $25.806 million LP is only one legal layer inside a rapidly expanding Mare Liberum critical-technology platform: separate 2026 SEC records show a $150 million Mare Liberum Critical Technologies Fund LLC and a distinct Advanced Manufacturing Fund, meaning investors should not combine similarly named vehicles or assume they share identical investors, assets or economics.
Mare Liberum Critical Technologies Fund I, LP · CIK 0002151169Read article →Trimtab Impact SEC Form D Review 2026: $52M Corporate Equity Raise Behind an Impact-First Holding Company
Trimtab Impact Inc. is a verifiable Delaware corporation formed in 2024 whose September 18, 2026 Form D reports a fixed $51,999,999 Equity offering fully sold to eight investors, leaving $0 remaining after a first sale on September 9. The issuer relies on Rule 506(b), is not classified as a pooled investment fund, clai
Trimtab Impact Inc. · CIK 0002126826Read article →Whisper Aero SEC Form D Review 2026: $46.3M Sold as Its Quiet Electric Propulsion Moves From Defense to Consumer Products
Whisper Aero Inc. is a verifiable Delaware operating company whose September 17, 2026 Form D reports a fully subscribed $46,317,349 Equity offering under Rule 506(b), with all $46,317,349 sold to 16 investors after a first sale on September 2. The filing lists Mark Moore and Ian Villa as executive officers, directors a
Whisper Aero Inc. · CIK 0001984798Read article →01 Advisors Fund IV SEC Form D Review 2026: Why Dick Costolo and Adam Bain Set Another $395M Target
01 Advisors 04, L.P. is a newly formed 2026 Delaware venture capital fund and the fourth numbered flagship vehicle in the 01 Advisors family. Its September 16 Form D sets a fixed $395 million offering under Rule 506(b) and Section 3(c)(7), but first sale has not yet occurred: the filing reports $0 sold, $395 million re
01 Advisors 04, L.P. · CIK 0002115466Read article →Is Mare Liberum Critical Technologies Fund I, LP Legit? SEC Form D Review 2026: $25.8M Sold, 17 Investors and the $150M Maritime SBICCT Strategy
Mare Liberum Critical Technologies Fund I, LP is a verifiable 2025 Delaware pooled investment fund whose new Form D was filed on September 15, 2026 after a first sale on August 31. The filing reports an indefinite offering with $25,805,500 sold to 17 investors, Rule 506(c), Section 3(c)(1), pooled investment fund interests, a technical $0 minimum investment and $0 estimated sales commissions or finder's fees. Mare Liberum Critical Technologies Fund I GP, LLC is the General Partner; Mare Liberum Capital Partners, LLC is identified as the management company; and Erik Bethel, Marc Baliotti, Vrushank Vora and retired Rear Admiral Lorin Selby appear in the related-person chain. BHA Select Network, LLC, CRD 168883, is named in the sales-compensation section for solicitation in Florida, Massachusetts and New York even though the filing estimates commissions at $0. The fund also states that the management company will receive management fees based on securities sold. This is therefore not an anonymous defense-tech shell: the SEC issuer, management company, named principals and Mare Liberum's public maritime-investment platform all connect directly. :contentReference[oaicite:0]{index=0}
Mare Liberum Critical Technologies Fund I, LP · CIK 0002151169Read article →UV Labs AI SEC Form D Review 2026: $5M Offering, Cod3x's $400M Trading History and a Leadership Record Mismatch
UV Labs AI, Inc. is a verifiable 2026 Delaware technology corporation attempting to raise $5 million, but its first Form D shows that the fundraising process was still extremely early when filed: only $35,000 had been sold to two investors, leaving $4.965 million remaining. The offering relies on Rule 506(b), carries a
UV Labs AI, Inc. · CIK 0002155383Read article →Is Mare Liberum Critical Technologies Fund I, LP Legit? SEC Form D Review 2026: $25.806M Sold, 17 Investors and a $150M Maritime Critical-Tech Leverage Facility
Mare Liberum Critical Technologies Fund I, LP is a verifiable 2025 Delaware pooled investment fund whose September 15, 2026 SEC Form D reports $25,805,500 sold to 17 investors in an indefinite offering. The fund relies on Rule 506(c) and Section 3(c)(1), offers pooled investment fund interests, reports no sales commissions or finder's fees, and identifies Mare Liberum Critical Technologies Fund I GP, LLC as General Partner, Mare Liberum Capital Partners, LLC as Management Company, and Erik Bethel as Managing Member of the General Partner. The filing also states that the management company will receive management fees based on securities sold. What makes this vehicle unusual is not merely that it is a defense-tech fund: Mare Liberum has built an investment thesis specifically around maritime dominance, naval modernization and the industrial systems needed to secure sea lanes, while the sponsor publicly says the fund has access to up to $150 million of low-cost government-backed leverage through the Small Business Administration and the U.S. Department of Defense Office of Strategic Capital framework. That creates a capital structure very different from a conventional venture fund funded only by LP equity. :contentReference[oaicite:0]{index=0}
Mare Liberum Critical Technologies Fund I, LP · CIK 0002151169Read article →Is Mare Liberum Critical Technologies Fund I, LP Legit? SEC Form D Review 2026: $25.81M Sold, 17 Investors and a Maritime National-Security Technology Strategy
Mare Liberum Critical Technologies Fund I, LP is a verifiable 2025 Delaware pooled investment fund whose September 15, 2026 SEC Form D reports an indefinite offering with $25,805,500 sold to 17 investors after a first sale on August 31, 2026. The fund relies on Rule 506(c) and Section 3(c)(1), offers pooled investment fund interests, reports a technical $0 minimum investment, $0 estimated sales commissions and $0 finder's fees, and states that its management company will receive management fees based on the amount of securities sold. Mare Liberum Critical Technologies Fund I GP, LLC is the General Partner, Mare Liberum Capital Partners, LLC is the Management Company, and Erik Bethel, Marc Baliotti, Rear Admiral Lorin Selby and Vrushank Vora appear in the related-person chain. BHA Select Network, LLC, CRD 168883, is listed as a sales-compensation recipient for solicitation in Florida, Massachusetts and New York even though Item 15 currently estimates $0 commissions. The unusual part is not simply that this is another defense-tech fund; Mare Liberum has built a narrow thesis around the maritime domain, where autonomous vessels, subsea systems, satellite connectivity, naval modernization, shipbuilding and maritime AI are treated as critical infrastructure rather than as isolated venture categories. :contentReference[oaicite:0]{index=0}
Mare Liberum Critical Technologies Fund I, LP · CIK 0002151169Read article →Tempo Therapeutics SEC Form D Review 2026: $14M Debt Sold After TT101's First-in-Human Trial and FDA De Novo Submission
Tempo Therapeutics, Inc. is a verifiable San Diego regenerative-medicine company whose September 11, 2026 Form D documents a $14.5 million private financing with an unusual feature that the later press announcement does not emphasize: the SEC filing classifies the security as Debt, not Equity. Tempo reported $14 millio
Tempo Therapeutics, Inc. · CIK 0001813688Read article →Is Arroyo Investors Fund V, L.P. Legit? SEC Form D Review 2026: $0-Sold Launch, 506(c) Fundraising and a $1B+ Fund IV Predecessor
Arroyo Investors Fund V, L.P. is a verifiable 2026 Delaware private-equity fund sponsored by Arroyo Energy Investment Partners, and its September 16, 2026 Form D is clearly a launch-stage filing rather than evidence of a completed raise. The issuer reports an indefinite offering, $0 sold, zero investors and "first sale yet to occur," while relying on Rule 506(c) and Section 3(c)(7) and offering both equity and pooled investment fund interests. Arroyo Investors Fund V GP, L.P. is the General Partner, while founding partners David T. Field and Robert C. Jordan appear in the related-person chain. The filing is already institutionally significant because it names a broad fundraising network — Threadmark LP, Threadmark Partners Limited, Threadmark LLP, Threadmark Unipessoal, Moonvalley Capital y Asesorias Limitada and Campbell Lutyens & Co. Inc. — and estimates $8,602,880 of sales commissions. The distinctive story is therefore not current fundraising volume, because Fund V was still at $0 sold; it is that Arroyo is launching a new 506(c) flagship immediately after closing Fund IV with more than $1 billion of commitments and after materially expanding its energy-infrastructure strategy into data centers, distributed generation, LNG and dark fiber.
Arroyo Investors Fund V, L.P. · CIK 0002147350Read article →